Is Insmed Incorporated (INSM) a Buy, Sell, or Hold?
NASDAQ : INSM
Insmed Incorporated — Analyst Ratings
$98.6 USD
-$2.89 (-2.85%)
- Volume
- 2.9M
- Average Volume
- 3.9M
- Market Capitalization
- $21.37B
- P/E Ratio
- -17.15
- Dividend Yield
- 0.00%
- Price Target
- $200.00
- Year High
- $212.75
- Year Low
- $90.39
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.47
Analyst Consensus Summary
Consensus Rating
Strong Sell
35 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-50.7%
vs Current Price
Price Target
$200.00
Average TargetPrice Target Range
Lowest Target
$161.00
-38.8% DOWNSIDE
Average Target
$200.00
Median Estimate
Highest Target
$235.00
-58.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 35
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 33 | 1 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Olivia Brayer | $235 | $104.16 | 2026-07-28 09:44 AM | 125.6% |
| BMO Capital | Conor MacKay | $192 | $107.02 | 2026-07-20 04:46 PM | 79.4% |
| H.C. Wainwright | Andrew Fein | $220 | $108.32 | 2026-07-20 06:44 AM | 103.1% |
| Mizuho Securities | Graig Suvannavejh | $192 | $97.46 | 2026-06-16 06:40 AM | 97.0% |
| Guggenheim | Vamil Divan | $226 | $105 | 2026-05-08 07:11 AM | 115.2% |